Cargando…

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction

Ivabradine is an established treatment for chronic heart failure with reduced ejection fraction (HFrEF); however, it is not used for acute heart failure treatment. Negative inotropic effects (NIE) often limit the up‐titration of β‐blockers. Contrarily, ivabradine has no NIE, and enables β‐blockers u...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Tomoko, Matsunaga, Keiji, Kobayashi, Waki, Minamino, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984869/
https://www.ncbi.nlm.nih.gov/pubmed/36879680
http://dx.doi.org/10.1002/ccr3.6890
_version_ 1784900827933048832
author Inoue, Tomoko
Matsunaga, Keiji
Kobayashi, Waki
Minamino, Tetsuo
author_facet Inoue, Tomoko
Matsunaga, Keiji
Kobayashi, Waki
Minamino, Tetsuo
author_sort Inoue, Tomoko
collection PubMed
description Ivabradine is an established treatment for chronic heart failure with reduced ejection fraction (HFrEF); however, it is not used for acute heart failure treatment. Negative inotropic effects (NIE) often limit the up‐titration of β‐blockers. Contrarily, ivabradine has no NIE, and enables β‐blockers usage for treating patients with acute decompensated HFrEF.
format Online
Article
Text
id pubmed-9984869
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99848692023-03-05 Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction Inoue, Tomoko Matsunaga, Keiji Kobayashi, Waki Minamino, Tetsuo Clin Case Rep Case Report Ivabradine is an established treatment for chronic heart failure with reduced ejection fraction (HFrEF); however, it is not used for acute heart failure treatment. Negative inotropic effects (NIE) often limit the up‐titration of β‐blockers. Contrarily, ivabradine has no NIE, and enables β‐blockers usage for treating patients with acute decompensated HFrEF. John Wiley and Sons Inc. 2023-03-04 /pmc/articles/PMC9984869/ /pubmed/36879680 http://dx.doi.org/10.1002/ccr3.6890 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Inoue, Tomoko
Matsunaga, Keiji
Kobayashi, Waki
Minamino, Tetsuo
Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
title Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
title_full Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
title_fullStr Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
title_full_unstemmed Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
title_short Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
title_sort successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984869/
https://www.ncbi.nlm.nih.gov/pubmed/36879680
http://dx.doi.org/10.1002/ccr3.6890
work_keys_str_mv AT inouetomoko successfultreatmentwithivabradineinabblockerrefractorypatientwithacutedecompensatedheartfailurewithreducedejectionfraction
AT matsunagakeiji successfultreatmentwithivabradineinabblockerrefractorypatientwithacutedecompensatedheartfailurewithreducedejectionfraction
AT kobayashiwaki successfultreatmentwithivabradineinabblockerrefractorypatientwithacutedecompensatedheartfailurewithreducedejectionfraction
AT minaminotetsuo successfultreatmentwithivabradineinabblockerrefractorypatientwithacutedecompensatedheartfailurewithreducedejectionfraction